[Indications for indomethacin rheumatic disease with special reference to its combination with immunosuppressive agents].
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D007213:Indomethacin / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D010396:Penicillamine / Q000008:administration & dosage; D011033:Podophyllin / Q000008:administration & dosage
D006834:Hydrazines; D007166:Immunosuppressive Agents; D011033:Podophyllin; D010396:Penicillamine; D007213:Indomethacin
Zur Indikation von Indometacin bei rheumatischen Erkrankungen unter besonderer Berücksichtigung der Kombinationsoöglichkeit mit Immunsuppressiva.